# Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

> **NCT02702960** · PHASE2 · WITHDRAWN · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins**

## Conditions studied

- Fibrolamellar Hepatocellular Carcinoma
- Hepatocellular Carcinoma (Fibrolamellar Variant)
- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** living related donor partial liver transplantation
- **RADIATION:** Total body irradiation
- **PROCEDURE:** Bone marrow transplant from same donor
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna
- **DRUG:** Filgrastim
- **DRUG:** Tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** Prednisone
- **DRUG:** Antithymocyte globulin
- **DRUG:** fludarabine

## Key facts

- **NCT ID:** NCT02702960
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2018-01-03
- **Final completion:** 2018-01-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was withdrawn due to lack of necessary resources from the liver transplant surgical group.
- **Last updated:** 2018-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702960, "Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02702960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*